{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:38:08Z","timestamp":1771929488526,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.eururo.2006.07.022","type":"journal-article","created":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T14:36:57Z","timestamp":1154961417000},"page":"684-710","source":"Crossref","is-referenced-by-count":84,"title":["Botulinum Toxin Injections for Neurogenic and Idiopathic Detrusor Overactivity: A Critical Analysis of Results"],"prefix":"10.1016","volume":"50","author":[{"given":"Anand K.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.07.022_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncpuro0034","article-title":"Botulinum toxin in urology: evaluation using an evidence-based approach","volume":"1","author":"Smith","year":"2004","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","article-title":"Botulinum toxin\u2014new mechanisms, new therapeutic directions?","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2006.07.022_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","article-title":"Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients","volume":"155","author":"Schurch","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib10","first-page":"609","article-title":"Botulinum toxin A (Botox) in neurogenic urinary incontinence: results from a multicentre randomised, controlled trial","volume":"23","author":"Schurch","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.07.022_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib12","unstructured":"Schurch B, De Seze M, Denys P, et al. Subgroup analysis to determine impact of patient demographics on urodynamic response to focal administration of botulinum toxin A. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 92)."},{"key":"10.1016\/j.eururo.2006.07.022_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.07.022_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib16","unstructured":"Corcos J, Al-Taweel W, Pippi Salle J, Capolicchio G, Jednak R. The treatment of detrusor hyperreflexia using botulinum A toxin in myelomeningocele patients unresponsive to anticholinergic. International Continence Society Annual Meeting, Heidelberg, Germany, Aug. 28\u201330, 2002 (abstract no. 39)."},{"key":"10.1016\/j.eururo.2006.07.022_bib17","unstructured":"Popat R, Apostolidis A, Fowler C, Dasgupta P. Botulinum toxin works as well in the short term in idiopathic detrusor overactivity (IDO) as in neurogenic detrusor overactivity (NDO). Joint meeting of the International Continence Society (ICS) and the International Uro-Gynaecological Association (IUGA), Paris, France, Aug. 25\u201327, 2004 (abstract no. 175)."},{"key":"10.1016\/j.eururo.2006.07.022_bib18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib19","first-page":"351","article-title":"Successful use of bladder botulinum toxin injection to treat refractory overactive bladder","volume":"169","author":"Chancellor","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib20","unstructured":"Sweeney D, O\u2019Leary M, Erickson J, Marx S, Chancellor MB. Safety and efficacy with bladder botulinum toxin in elderly patients. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 453)."},{"key":"10.1016\/j.eururo.2006.07.022_bib21","unstructured":"Sahai A, Khan M, Smith K, Dasgupta P. Botulinum toxin-A for patients with idiopathic detrusor overactivity: early results from a randomised, double-blind, placebo-controlled trial. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 428)."},{"key":"10.1016\/j.eururo.2006.07.022_bib22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eururo.2006.07.022_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","article-title":"Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics","volume":"66","author":"Kuo","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.07.022_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","article-title":"Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.07.022_bib25","unstructured":"Hoebeke P, Decaestecker K, Verleyen P, et al. Extended experience with the use of botulinum toxin A in children with non neurogenic voiding dysfunction. ESPU-AAP Joint Conference 2005. Uppsala, Sweden, June 15\u201318, 2005 (abstract no. 109)."},{"key":"10.1016\/j.eururo.2006.07.022_bib26","unstructured":"Peeren F, Everaert K, Hoebeke P, Decaestecker K. Successive injections of botulinum A toxin (Botox) in paediatric population. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 270)."},{"key":"10.1016\/j.eururo.2006.07.022_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","article-title":"Botulinum toxin as a new therapy option for voiding disorders: current state of the art","volume":"44","author":"Leippold","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2003.04714.x","article-title":"Botulinum toxin and its applications in the lower urinary tract","volume":"93","author":"Harper","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.07.022_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/0929867053363315","article-title":"Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin","volume":"12","author":"Maria","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.eururo.2006.07.022_bib30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib31","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1046\/j.1526-4610.43.7s.1.x","article-title":"Botulinum toxin type A: myths, facts, and current research headache","volume":"43","author":"Silberstein","year":"2003","journal-title":"J Head Face Pain"},{"key":"10.1016\/j.eururo.2006.07.022_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","article-title":"Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity","volume":"171","author":"Reitz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib33","unstructured":"Truzzi JC, Bruschini H, Simonetti R, Miguel S. What is the best dose for intravesical botulinum-A toxin injection in overactive bladder treatment? A prospective randomised preliminary study. Joint Meeting of the International Continence Society (ICS) and the International Uro-Gynaecological Association (IUGA), Paris, France, Aug. 25\u201327, 2004 (abstract no. 520)."},{"key":"10.1016\/j.eururo.2006.07.022_bib34","unstructured":"Gousse A, Tunuguntla HSGR, Rodriguez D, Velazquez D. Dose-finding prospective randomized study to evaluate the efficacy and safety of botulinum-A toxin for refractory idiopathic overactive bladder. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract 254)."},{"issue":"1","key":"10.1016\/j.eururo.2006.07.022_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1569-9056(02)80519-X","article-title":"Botulinum toxin type A intravesical injections for intractable bladder overactivity","volume":"1","author":"Radziszewski","year":"2002","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2006.07.022_bib36","unstructured":"Del Popolo G, Li Marzi V, Panariello G, Lombardi G. English botulinum toxin-A in the treatment of neurogenic detrusor overactivity. International Continence Society Annual Meeting, Florence, Italy, Oct. 7\u20139, 2003 (abstract no. 96)."},{"key":"10.1016\/j.eururo.2006.07.022_bib37","first-page":"521","article-title":"Botulinum toxin-A to treat detrusor hyperreflexia in spinal cord injured patients","volume":"20","author":"Schurch","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.07.022_bib38","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.07.022_bib39","doi-asserted-by":"crossref","unstructured":"Karsenty G, Boy S, Reitz A, et al. Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI)\u2014a prospective randomized study to compare 30 vs. 10 injection sites. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 93).","DOI":"10.1016\/S1569-9056(07)60885-9"},{"key":"10.1016\/j.eururo.2006.07.022_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.07.022_bib41","first-page":"412","article-title":"Trigonum and bladder base injection of botulinum toxin A (BTX) in patients with severe urgency-frequency syndrome refractory to conservative medical treatment and electrical stimulation","volume":"20","author":"Zermann","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.07.022_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1310\/1640-XEPP-Y33E-TMK8","article-title":"Botulinum-A toxin injections as a treatment for refractory detrusor hyperreflexia","volume":"8","author":"Kennelly","year":"2003","journal-title":"Top Spinal Cond Inj Rehabil"},{"key":"10.1016\/j.eururo.2006.07.022_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","article-title":"Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity","volume":"40","author":"Wyndaele","year":"2002","journal-title":"Spinal Cord"},{"key":"10.1016\/j.eururo.2006.07.022_bib44","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","article-title":"Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction","volume":"48","author":"Schulte-Baukloh","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib45","unstructured":"Karsenty G, Lindemann G, Reitz A, et al. The effect of repeated injections of botulinum toxin type A on the efficacy of the treatment of neurogenic overactive bladder and the urinary bladder. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 242)."},{"key":"10.1016\/j.eururo.2006.07.022_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11934-004-0088-5","article-title":"Urologic applications of botulinum toxin therapy for voiding dysfunction","volume":"5","author":"Rackley","year":"2004","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.eururo.2006.07.022_bib47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","article-title":"Botulinum toxin type B for type A resistant bladder spasticity","volume":"171","author":"Pistolesi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib48","unstructured":"Hirst G, Wareham K, Emery S, Lucas M. Failure of botulinum toxin type B in the treatment of the refractory overactive bladder. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 432)."},{"key":"10.1016\/j.eururo.2006.07.022_bib49","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","article-title":"Treatment of overactive bladder with botulinum toxin type B: a pilot study","volume":"14","author":"Dykstra","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2006.07.022_bib51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.mou.0000172401.92761.86","article-title":"Botulinum toxin injections for paediatric incontinence","volume":"15","author":"Schurch","year":"2005","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib52","first-page":"386","article-title":"Repeat detrusor injections of botulinum A toxin in patients with neurogenic lower urinary tract dysfunction do not cause increased drug tolerance","volume":"21","author":"Grosse","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.07.022_bib53","first-page":"79","article-title":"New therapeutic options for refractory neurogenic detrusor overactivity","volume":"56","author":"Giannantoni","year":"2004","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.eururo.2006.07.022_bib54","unstructured":"Thoulouzan M, Soler JM, Soulie M, et al. Prospective evaluation of botulinum toxin A (Botox\u00ae) in neurogenic urinary incontinence. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 261)."},{"issue":"1","key":"10.1016\/j.eururo.2006.07.022_bib55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1569-9056(03)80680-2","article-title":"Botulinum-A toxin detrusor injections in the treatment of non-neurologic and neurologic cases of urge incontinence","volume":"2","author":"Loch","year":"2003","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2006.07.022_bib56","unstructured":"Patki P, Arumungam K, Hamid R, Shar PJR, Craggs M. Day case treatment of resistant neurogenic detrusor overactivity, following spinal cord injury. British Association of Urological Surgeons Annual Meeting, Glasgow, UK, June 27\u2013July 1, 2005 (abstract no. 62)."},{"key":"10.1016\/j.eururo.2006.07.022_bib57","unstructured":"Giannantoni A, Nardicchi V, Di Stasi S, et al. Botulinum A toxin intravesical injections reduce nerve growth factor bladder tissue content in patients affected by neurogenic detrusor overactivity. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 221)."},{"key":"10.1016\/j.eururo.2006.07.022_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-5347(18)37779-6","article-title":"A single surgeon\u2019s six-year experience with botulinum toxin injection into the bladder and urethra","volume":"171","author":"Chancellor","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.07.022_bib60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","article-title":"Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions","volume":"38","author":"Bagi","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2006.07.022_bib61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.022_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.07.022_bib63","unstructured":"Toh K, Tow A, Consigliere D. Botulinum toxin type A for refractory detrusor overactivity in patients with spinal cord injuries in Asia: preliminary results. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 433)."},{"key":"10.1016\/j.eururo.2006.07.022_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.07.022_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1569-9056(03)80558-4","article-title":"Therapy of neurogenic and non neurogenic detrusor overactivity with detrusor-injections of botulinum-a toxin and continent vesicostomy","volume":"2","author":"Schumacher","year":"2003","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2006.07.022_bib66","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0003-9993(03)00202-8","article-title":"Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report","volume":"84","author":"Dykstra","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.eururo.2006.07.022_bib67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1569-9056(05)80563-9","article-title":"Experience of 100 cases treated with botulinum-A toxin injections into the detrusor muscle for overactive bladder refractory to anticholinergics","volume":"4","author":"Schmid","year":"2005","journal-title":"Eur Urol Suppl"},{"issue":"2","key":"10.1016\/j.eururo.2006.07.022_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1569-9056(04)90513-1","article-title":"Botulinum toxin injections to treat overactive bladder","volume":"3","author":"Schmid","year":"2004","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2006.07.022_bib69","unstructured":"Kalsi V, Popat R, Odyemi I, et al. A cost effectiveness model for botulinum neurotoxin type A (BoNT\/A) in the treatment of patients with detrusor overactivity: preliminary results. British Association of Urological Surgeons Annual Meeting, Glasgow, UK, June 27\u2013July 1, 2005 (abstract no. 61)."},{"key":"10.1016\/j.eururo.2006.07.022_bib70","doi-asserted-by":"crossref","unstructured":"Abdelmalak JB, Rackley RR, Vasavada SP, et al. Botulinum A toxin (Botox) injection for the treatment of refractory overactive bladder. American Urological Association Annual Meeting, San Francisco, CA, USA, May 8\u201313, 2004 (abstract no. 531).","DOI":"10.1016\/S0022-5347(18)37793-0"},{"key":"10.1016\/j.eururo.2006.07.022_bib71","unstructured":"Werner M, Schmid D, Schurch B, Schuessler B. Efficacy of botulinum-A toxin in the treatment of refractory overactive bladder syndrome: preliminary results of a prospective non-randomized study. International Continence Society Annual Meeting, Paris, France, Aug. 25\u201327, 2004 (abstract no. 168)."},{"key":"10.1016\/j.eururo.2006.07.022_bib72","first-page":"1216","article-title":"Intradetrusor injections of botulinum A toxin to treat severe detrusor overactivity","volume":"75","author":"Fowler","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.eururo.2006.07.022_bib73","unstructured":"Keppenne V, Gaspard Y, Mathantu B, Sanjurjo S, de Leval J. Detrusor injection of botulinum A toxin for idiopathic overactive bladder syndrome: clinical and urodynamic evaluation. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31\u2013Sep. 2, 2005 (abstract no. 498)."},{"key":"10.1016\/j.eururo.2006.07.022_bib74","unstructured":"Mustafa AW, Small DR, Rajkumar GN, Conn IG. A quantitative assessment of the effect of botulinum toxin type A on voiding detrusor contractility. British Association of Urological Surgeons Annual Meeting, Glasgow, UK, June 27\u2013July 1, 2005 (abstract no. 59)."},{"key":"10.1016\/j.eururo.2006.07.022_bib75","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","article-title":"A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity","volume":"96","author":"Rajkumar","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.07.022_bib76","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.ju.0000143889.00681.3f","article-title":"The effect of botulinum-A toxin on patients with severe urge urinary incontinence","volume":"172","author":"Flynn","year":"2004","journal-title":"J Urol"},{"issue":"Suppl 2","key":"10.1016\/j.eururo.2006.07.022_bib77","first-page":"96","article-title":"The use of botulinum toxin A in children with a non-neurogenic overactive bladder: a pilot study","volume":"93","author":"Verleyen","year":"2004","journal-title":"BJU Int"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806008578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806008578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T14:48:54Z","timestamp":1555771734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806008578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0302283806008578"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.07.022","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}